Jon E. Arnason, MD¹, Jurriaan Brouwer-Visser^2*, Stefano Luminari, MD³, David Tucker^4*, Tae Min Kim, MD, PhD^5*, Won Seog Kim, MD^6*, Laura Magnano, MD, PhD^7*, Dylan Sun^2*, Jessica Cai^2*, Kamil Cygan^2*, Srikanth Ambati^2*, Hesham Mohamed², Aafia Chaudhry² and Vladimir Jankovic^2*

¹Beth Israel Deaconess Medical Center, Boston, MA
²Regeneron Pharmaceuticals, Inc., Tarrytown, NY
³Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy
⁴Royal Cornwall Hospital, Cornwall, United Kingdom
⁵Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁶Samsung Medical Center, Center for Hematologic Malignancy, Seoul, Korea, Republic of (South)
⁷Department of Hematology, Hospital Clínic, Barcelona, Barcelona, Spain

Dylan J. Tatterton, MSc^1*, Benjamin Sale, MSc^1*, Joel Allen, PhD^2*, Maddy L. Newby, BSc (Hons)^2*, Giorgia Chiodin, PhD^1*, Patrick J. Duriez, PhD^1*, John Butler^2*, Katy J. McCann, PhD^1*, David W. Scott, MBChB, PhD³, Ryan Morin, PhD⁴, Andrew S. Davies, BSc (Hons) BM (Hons) PhD FRCP^5*, Dean J. Bryant, PhD^1*, Freda K. Stevenson, DPhil¹, Max Crispin, DPhil, FRSB, FRSC, FHEA^2* and Francesco Forconi, MD, PhD, DM, FRCPath^1,6*

¹School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
²Biological Sciences, University of Southampton, Southampton, United Kingdom
³Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
⁴Genome Sciences Center, BC Cancer Research Institute, Vancouver, BC, Canada
⁵Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, United Kingdom
⁶Department of Haematology, Southampton University Hospital Trust, Southampton, United Kingdom

Zijun Y. Xu-Monette, PhD^1*, Yong Li, PhD², Thomas Snyder^3*, Tiantian Yu, PhD^4*, Tingxun LU^4*, Alexandar Tzankov^5*, Carlo Visco, MD^6*, Govind Bhagat, MD⁷, Wenbin Qian^8*, Karen Dybkaer, PhD, MSC^9*, April Chiu, MD^10*, Wayne Tam, MD¹¹, Youli Zu, MD, PhD^12*, Eric D. Hsi, MD¹³, Frederick Hagemeister^14*, Heounjeong Go^15*, Maurilio Ponzoni, MD¹⁶, Andrés José María Ferreri, MD¹⁷, Michael Møller^18*, Benjamin M. Parsons, DO¹⁹, Joannes H.J.M. Van Krieken, PhD, MD^20*, Yingjun Wang, MD^21*, Miguel Angel Piris, PhD, MD^22*, Jane Winter²³, Qingyan Au^24*, Ilan Kirsch^25*, Mingzhi Zhang, MD^26*, John D Shaughnessy, Jr, PhD^27*, Bing Xu^28* and Ken H. Young, MD, PhD²⁹

¹Department of Pathology, Duke University Medical Center, Durham, NC
²Medicine, Baylor College of Medcine, Houston, TX
³Adaptive Biotechnologies, Seattle, WA
⁴Duke University, Durham, NC
⁵Medical University Basel, Basel, Switzerland
⁶University of Verona, Verona, ITA
⁷Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York
⁸The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁹Aalborg University Hospital, Aalborg, Denmark
¹⁰Mayo Clinic, Rochester, MN
¹¹Well Cornell Medical College, New York, NY
¹²Houston Methodist Hospital, Houston, TX
¹³Wake Forest Baptist Medical Center, Winston Salem, NC
¹⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Cente, Houston, TX
¹⁵Asan Medical Center Children's Hospital, Seoul, KOR
¹⁶Pathology Unit, San Raffaele H. Scientific Institute, Milano, Italy
¹⁷Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
¹⁸Odense University Hospital, Odense, Denmark
¹⁹Gundersen Lutheran Health System, La Crosse, WI
²⁰University Hospital Nijmegen, Nijmegen, NLD
²¹The first affiliated hospital of Zhengzhou University, Zhengzhou, CHN
²²Hospital Universitario Marques Valdecilla, Santander, Cantabria, ESP
²³Robert H. Lurie Comp. Cancer Center, Chicago, IL
²⁴NeoGenomics Laboratories, Aliso Viejo, CA
²⁵Adaptive Biotechnologies, Seattle
²⁶the First Affiliated Hospital of Zhengzhou University, Zhengzhou, CHN
²⁷University of Arkansas For Medical Sciences, Little Rock, AR
²⁸The First Affiliated Hospital of Xiamen University and Institute of Hematology, Xiamen, China
²⁹Duke Cancer Institute, Duke University Medical Center, Durham, NC

Yoshiaki Abe, MD, PhD^1*, Junko Zenkoh^2*, Daisuke Ikeda^3*, Sawa Aya^4*, Daisuke Kaji, MD, PhD^5*, Rikako Tabata^6*, Ryota Matsuoka, MD, PhD^7*, Manabu Fujisawa^8*, Kenichi Makishima, MD, PhD^9*, Sakurako Suma, MD, PhD^9*, Keiichiro Hattori^10*, Yasuhito Suehara, MD, PhD^11*, Tatsuhiro Sakamoto^12*, Chikashi Yoshida^13*, Hiroko Bando^14*, Ayako Suzuki^2*, Yasunori Ota, MD, PhD^15*, Yoshihito Otsuka^16*, Kosei Matsue⁶, Shigeru Chiba^12*, Yutaka Suzuki, PhD^17* and Mamiko Sakata-Yanagimoto¹²

¹Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
²The University of Tokyo, Tokyo, Japan
³Division of Hematology/Oncology, Kameda Medical Center, Kamogawa-Shi, CHI, Japan
⁴Department of Breast-Thyroid-Endocrine Surgery, University of Tsukuba Hospital, Tsukuba, Japan
⁵Department of Hematology, Toranomon Hospital, Tokyo, Japan
⁶Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan
⁷Department of Pathology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
⁸Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, Canada
⁹Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan
¹⁰Department of Hematology, University of Tsukuba Hospital, Washington, DC
¹¹University of Tsukuba Hospital, Tsukuba, Japan
¹²Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
¹³National Hospital Organization Mito Medical Center, Mito, Japan
¹⁴Department of Breast and Endocrine Surgery, University of Tsukuba, Tsukuba, Japan
¹⁵Department of Pathology, The Institute of Medical Science Research Hospital, The University of Tokyo, Tokyo, Japan
¹⁶Department of Clinical Laboratory, Kameda Medical Center, Kamogawa, Japan
¹⁷Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan

Jon Celay, PhD^1*, Miriam Recalde, PhD^2*, María Victoria Revuelta, PhD^3*, Marta Larrayoz, PhD^2*, Sara Rodriguez, PhD^2*, Maria J Garcia-Barchino, PhD^2*, Jennifer R. Chapman-Fredricks, MD^4*, Teresa Lozano, PhD^5*, Juan J Lasarte, PhD^5*, Ming Q. Du, MD^6*, Izidore S. Lossos, MD⁷, Sergio Roa, PhD^8*, Aldo Roccaro, MD, PhD⁹, Miguel Canales^10*, Felipe Prosper, MD, PhD¹¹, Bruno Paiva^11*, Leandro Cerchietti, MD¹² and Jose A. Martinez-Climent, MD/PhD²

¹Hematology and Oncology Program, Centre for Applied Medical Research (CIMA), Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain
²Center for Applied Medical Research, Clinica University of Navarra Cancer Center, University of Navarra, Pamplona, Spain
³Weill Cornell Medicine, New York, NY
⁴Department of Pathology and Laboratory Medicine, University of Miami, Miami, FL
⁵Immunology and Immunotherapy Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
⁶Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
⁷Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
⁸Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain
⁹Clinical Trial Center, Translational Research and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, BS, Italy
¹⁰Department of Hematology, Clínica Universidad de Navarra; Hematology and Oncology Program, Center for Applied Medical Research (CIMA); Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Pamplona, Spain
¹¹Cancer Center Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain
¹²Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medical College, New York, NY

Yusuke Isshiki, MD, PhD¹, Patrizia Porazzi, PhD^2*, Xi Chen, PhD^3*, Matthew Teater, PhD^1*, Ioannis Karagiannidis, PhD^3*, Henna S. Nam, BS^1*, Ari M Melnick, MD¹, Marco Ruella, MD⁴ and Wendy Beguelin, PhD^5*

¹Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
²Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
³Department of Medicine, Weill Cornell Medicine, New York, NY
⁴Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁵Department of Medicine, Weill Cornell Medical College, New York, NY